In an initial effort to determine the effect of expressing potentially ther
apeutic gene products on the growth properties of glioma tumor xenografts,
we describe the development of cell lines that can conditionally express be
ta -galactosidase (beta -gal). To achieve this, we generated stable cell li
nes that express the modifed tetracycline repressor molecule (rtTA) and the
beta -pal gene under control of tetracycline-responsive cis-elements. The
resulting cell lines express functional beta -gal following treatment with
the tetracycline analog doxycyclin (Dox). These cells were then used to for
m intracranial tumors after injection into the brain rising an implantable
guide-screw system. The xenografts were found to express beta -gal when the
animals were fed drinking water containing Dox. From these studies, we con
clude that the expression of a target gene in a human xenograft growing in
the brain of a living mouse crm be conditionally regulated.